tiprankstipranks

Thomas Anderson Insider Profile

4 Followers
Thomas Anderson, Chief Commercial Strategy Officer at SAGE Therapeutics, holds 20.00K shares in Zevra Therapeutics (Ticker: ZVRA), holds 1.55K shares in SAGE Therapeutics (Ticker: SAGE). Most recently, Thomas Anderson Bought ― shares of Zevra Therapeutics on Jul 16, 2024 for an estimated value of 68.00K.
tipranks
Thomas Anderson

Thomas Anderson
SAGE Therapeutics (SAGE)
Chief Commercial Strategy Officer

Ranked #13,771 out of 98,042 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+62.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$147K
86.44%
13.56%
A breakdown of Thomas Anderson's holdings

Insider Roles

Zevra Therapeutics
(ZVRA)
Director
SAGE Therapeutics
(SAGE)
Chief Commercial Strategy Officer
Roles that Thomas Anderson holds in companies

Most Profitable Insider Trade

Stock:
SAGE Therapeutics
(SAGE)
Rating:Informative Buy
Date:Jul 23, 2014 - Jul 23, 2015
Return:+173.30%
The most profitable trade made by Thomas Anderson

Thomas Anderson's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SAGE Therapeutics
Dec 19, 2016
Chief Commercial Strategy Officer
Uninformative Buy
13.86K
$19.89K
Zevra Therapeutics
Jul 16, 2024
Director
Informative Buy
68.00K
$126.80K
List of latest transactions for each holding click on a transaction to see Thomas Anderson's performance on stock

Thomas Anderson insider profile FAQ

What is the percentage of profitable transactions made by Thomas Anderson?
The percentage of profitable transactions made by Thomas Anderson is 67%.
    What is the average return per transaction made by Thomas Anderson?
    The average return per transaction made by Thomas Anderson is 62.40%.
      What stocks does Thomas Anderson hold?
      Thomas Anderson holds: SAGE, ZVRA stocks.
        What was Thomas Anderson’s latest transaction?
        Thomas Anderson latest transaction was an Informative Buy of $68.00K.
          What was Thomas Anderson's most profitable transaction?
          Thomas Anderson’s most profitable transaction was an Informative Buy of SAGE stock on July 23, 2014. The return on the trade was 173.30%.
            What is Thomas Anderson's role in SAGE Therapeutics?
            Thomas Anderson's role in SAGE Therapeutics is Chief Commercial Strategy Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.